herpes zoster
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged 50 years or older were diagnosed with head and facial herpes zoster; 2. Patients with rash within 2 weeks and receiving appropriate antiviral treatment.
Exclusion criteria
Exclusion criteria: 1. Patients refused to participate in the study; 2. Those who erupt for more than two weeks; 3. Those who did not receive appropriate antiviral therapy; 4. The head and neck were found to have neurological deficits or SCB infection; 5. Those who have cardiovascular, liver, blood, endocrine or other systemic diseases that make it difficult to complete clinical trials or to analyze the results of research; 6. Patients with diabetic neuralgia have a definite history of diabetes and diabetic peripheral neuropathy (DPN); 7. This study was preceded by SGB or other sympathetic blockades or a history of allergy to research drugs, drug excipients, or chemically similar drugs; 8. Having a history of autoimmune diseases, malignant diseases or known human acquired immunodeficiency syndrome (AIDS); 9. Can not cooperate with SGB or can not tolerate oral medication or have a history of obvious absorption disorders. 10. There was a history of drug abuse or alcohol abuse within 12 months before the start of the study; 11. Other research drugs were taken within 30 days before the start of the study; 12. During the study period, medication or other treatment is not acceptable; 13. Failure to complete the study due to mental illness or any other illness, interference with the clinical course of the study, or significant risk to the patient.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analogue Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| PSQI;PCT;CRP;Norepinephrine; | — |
Countries
China
Contacts
The First Affiliated Hospital of Shihezi University